Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cortexyme Inc (NQ: CRTX ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Jul 29, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Cortexyme Inc < Previous 1 2 3 4 Next > 28 Stocks Moving in Wednesday's Pre-Market Session October 27, 2021 Gainers China XD Plastics Company Limited (NASDAQ: CXDC) rose 139% to $1.40 in pre-market trading after jumping around 30% on Tuesday. Guardion Health Sciences, Inc. (NASDAQ:... Via Benzinga Why Cortexyme Shares Are Plunging 70% After Hours October 26, 2021 Shares of a clinical-stage biopharmaceutical company are falling in after-hours trading Tuesday after the company shared an update. What Happened: Cortexyme Inc (NASDAQ: CRTX)... Via Benzinga Why This Alzheimer's Study Missed, But That's Not Necessarily A Bad Thing For Cortexyme October 26, 2021 Cortexyme said Tuesday its experimental Alzheimer's drug might work in some patients. Via Investor's Business Daily Why Cortexyme Thinks It Could Be Next In The Mega Alzheimer's Drug Market October 21, 2021 Cortexyme is testing a twice-day pill to treat Alzheimer's disease. Via Investor's Business Daily Before The Bubble Bursts August 14, 2021 Maybe some good can come out of the market bubble -- for Alzheimer's patients, and for investors in Cortexyme. Via Talk Markets Analyzing Cortexyme's Unusual Options Activity August 09, 2021 On Monday, shares of Cortexyme (NASDAQ:CRTX) saw unusual ... Via Benzinga 51 Biggest Movers From Friday October 18, 2021 Gainers LM Funding America, Inc. (NASDAQ: LMFA) shares jumped 38.1% to close at $4.75 on Friday after declining around 15% on Thursday. The company recently announced it... Via Benzinga Cramer Likes Azek And SoFi, But Said Owning This Stock Could Be Dreadful October 08, 2021 On CNBC's "Mad Money Light... Via Benzinga 10 Biggest Price Target Changes For Thursday August 26, 2021 Keybanc raised the price target for Intuit Inc. (NASDAQ: Via Benzinga Cortexyme: Shifting The Odds In Your Favor So Your Best Case Outcome Is Three Times Higher Than Your Worst Case August 16, 2021 Screen capture via Cortexyme animation. A Bigger Bubble Than The Late '90s Phoenix Capital Research offered an interesting comparison of the current stock market to that... Via Benzinga The Week Ahead In Biotech: Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow August 15, 2021 Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small- and mid-cap companies among... Via Talk Markets Topics Initial Public Offering Exposures Securities Market The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow August 15, 2021 Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small-... Via Benzinga Topics Initial Public Offering Exposures Securities Market The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering August 11, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,... Via Benzinga Exposures Product Safety 85 Biggest Movers From Yesterday August 11, 2021 Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX... Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session August 10, 2021 Gainers CohBar (NASDAQ:CWBR) shares incr... Via Benzinga The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts August 10, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (... Via Benzinga Exposures COVID-19 Stocks That Hit 52-Week Highs On Tuesday August 10, 2021 Before 10 a.m. ET on Tuesday, 100 stocks hit new 52-week highs. Things to Consider: The largest company by market cap to break to a new 52-week high was Pfizer (... Via Benzinga 68 Biggest Movers From Yesterday August 10, 2021 Gainers Golden Nugget Online Gaming, Inc. (NASDAQ: GNOG) shares climbed 50.8% to close at $18.50 on Monday after the company and DraftKings announced they entered into a... Via Benzinga Mid-Afternoon Market Update: Aterian Falls After Q2 Results; Select Interior Concepts Shares Spike Higher August 09, 2021 Toward the end of trading Monday, the Dow traded down 0.17% to 35,150.02 while the NASDAQ rose 0.26% to 14,874.23. The S&P also rose, gaining 0.01% to 4,436.62. The U.S. has... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Monday's Intraday Session August 09, 2021 Gainers SCWorx (NASDAQ:WORX) shares moved upwards by 33.66% to $4.3 during Monday's regular session. As of 12:30 EST, this security is trading at a volume of 87.6... Via Benzinga Mid-Day Market Update: Crude Oil Down 2.5%; Golden Nugget Online Gaming Shares Jump August 09, 2021 Midway through trading Monday, the Dow traded down 0.23% to 35,126.98 while the NASDAQ rose 0.20% to 14,866.01. The S&P also fell, dropping 0.08% to 4,432.96. The U.S. has the... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Cortexyme Selects 3CLpro Inhibitor As COVID-19 Candidate July 23, 2021 Cortexyme Inc (NASDAQ: CRTX) has selected COR803 to further evaluate for coronavirus infections, including COVID-19 disease. COR803 is a novel patent-pending small... Via Benzinga Exposures COVID-19 The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, AbSci IPO July 22, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 21) Biohaven Pharmaceutical... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO August 06, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)... Via Benzinga The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More July 25, 2021 Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start... Via Benzinga Exposures Product Safety Biogen Stock Drags On Alzheimer's Players As FDA Requests Review Of Aduhelm Approval July 09, 2021 Biogen stock tumbled Friday after the FDA requested an independent review of the process that led to its recent Alzheimer's approval. Via Investor's Business Daily Exposures Product Safety The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs July 23, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 22) Bio-Techne Corporation (... Via Benzinga Biogen Snagged: Will Hefty Price Tag Hinder Alzheimer's Drug Use? June 08, 2021 Biogen stock dipped Tuesday as analysts questioned how much use its potential blockbuster Alzheimer's treatment, Aduhelm, would ultimately secure. Via Investor's Business Daily The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs June 25, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 24) AngioDynamics, Inc. (NASDAQ... Via Benzinga Exposures COVID-19 Biogen Wins Landmark Alzheimer's Approval: 5 Things To Know About Aducanumab June 07, 2021 The FDA approved Biogen's Alzheimer's treatment, aducanumab, on Monday — though Biogen stock remained halted into the long-awaited decision. Via Investor's Business Daily Exposures Product Safety < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.